Nanalysis Announces Grant of Options and Restricted Share Units

Rhea-AI Summary

Nanalysis (OTC:NSCIF, TSXV:NSCI) announced equity compensation grants to a director and officer. The board approved 100,000 stock options exercisable at $0.15 per share for five years and 100,000 restricted share units to an officer, under shareholder-approved equity plans.

Positive

• 100,000 stock options granted at $0.15 exercise price, five-year term
• 100,000 restricted share units granted under shareholder-approved RSU plan

Negative

• Equity grants create potential dilution of up to 200,000 common shares

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CALGARY, AB, July 3, 2026 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, FRA: 1N1) announces the Company's Board of Directors has granted 100,000 stock options ("Options") to a director and officer of the Company, pursuant to the Company's stock option plan. Each option is exercisable, once vested, to purchase one common share of the Company (a "Common Share") at $0.15 per share for a period of five years from the date of issuance.‎

In addition, the Company granted 100,000 restricted share units ("RSUs") to an officer of the Company, pursuant to the Company's restricted share unit plan  (the "RSU Plan").  Each vested RSU entitles the holder to receive one Common Share. The RSU Plan was approved by the shareholders of the Company at the annual general and special meeting held on September 22, 2025.

About Nanalysis Scientific Corp. (TSXV: NSCI, FRA: 1N1)

Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company also operates a growing services division that maintains both its own products and third-party imaging equipment, anchored by a $160 million long-term contract with the Canadian Air Transport Security Authority (CATSA) to maintain security scanners at more than 80 Canadian airports.

Notice regarding Forward Looking Information and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-grant-of-options-and-restricted-share-units-302817396.html

SOURCE Nanalysis Scientific Corp.

FAQ

What equity awards did Nanalysis (NSCIF) grant on July 3, 2026?

Nanalysis granted 100,000 stock options and 100,000 restricted share units to a director and an officer. According to Nanalysis, these awards were made under its stock option and restricted share unit plans.

What are the terms of the new Nanalysis (NSCIF) stock options?

The new Nanalysis stock options have a $0.15 exercise price and a five-year term. According to Nanalysis, each vested option allows purchase of one common share once vesting conditions are met.

How many restricted share units did Nanalysis (NSCIF) grant and to whom?

Nanalysis granted 100,000 restricted share units to an officer of the company. According to Nanalysis, each vested RSU entitles the holder to receive one common share under the restricted share unit plan.

Was the Nanalysis (NSCIF) RSU plan approved by shareholders?

Yes, the Nanalysis restricted share unit plan was approved by shareholders. According to Nanalysis, approval occurred at the annual general and special meeting held on September 22, 2025.

How could the July 2026 Nanalysis (NSCIF) option and RSU grants affect share count?

If fully exercised and vested, the July 2026 grants could add up to 200,000 shares. According to Nanalysis, each option and each RSU converts into one common share under the respective plans.